Huntington director granted additional HBAN shares

Tate Jeffrey L. reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Tate Jeffrey L. reported acquisition or exercise transactions in this Form 4 filing.

Huntington Bancshares director Jeffrey L. Tate reported stock awards rather than open‑market trades. On 2026-07-01, he received 44.146 shares of common stock credited to a Director Deferred Compensation Plan and 525.900 shares of common stock into a direct account, both at $0.0000 per share as compensation grants.

Following these awards, Tate’s reported holdings increased to 5,202.841 indirectly held shares and 123,460.753 directly held shares of Huntington Bancshares common stock. A disclaimer notes that this reporting should not be viewed as an admission of beneficial ownership under Section 16.

Insider Trade Summary

Grant/Award: 570.046 shares

Grant/Award 2 txns

Insider Tate Jeffrey L.

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	525.9	$0.00	$0.00
Grant/Award	Common Stock	44.146	$0.00	$0.00

Holdings After Transaction: Common Stock — 123,460.753 shares (Direct); Common Stock — 5,202.841 shares (Indirect, Director Deferred Compensation Plan)

Footnotes (1)

1. F1. The filing of this statement shall not be construed as an admission that the undersigned is, for the purpose of Section 16 of the Securities and Exchange Act of 1934 or otherwise, the beneficial owner of the securities.

Key Figures

Deferred plan award: 44.146 shares Direct stock award: 525.900 shares Award price: $0.0000 per share +2 more

5 metrics

Deferred plan award 44.146 shares Common Stock credited to Director Deferred Compensation Plan on July 1, 2026

Direct stock award 525.900 shares Common Stock grant to direct holdings on July 1, 2026

Award price $0.0000 per share Stated price for both compensation-related acquisitions

Indirect holdings after 5,202.841 shares Common Stock in Director Deferred Compensation Plan after awards

Direct holdings after 123,460.753 shares Directly held Common Stock after the July 1, 2026 grant

Key Terms

Director Deferred Compensation Plan, transaction code A, beneficial owner, Section 16

4 terms

Director Deferred Compensation Plan financial

"44.146 shares of common stock credited to a Director Deferred Compensation Plan"

transaction code A regulatory

"The transactions were classified with transaction code A as grant or award acquisitions"

beneficial owner regulatory

"not be construed as an admission that the undersigned is the beneficial owner of the securities"

A beneficial owner is the person who ultimately owns or controls a financial asset or property, even if their name isn't directly on official documents. Think of it like someone who secretly holds the keys to a safe deposit box—others may appear to have access, but the true owner is the one who benefits from what's inside. Identifying beneficial owners helps ensure transparency and prevent illegal activities like money laundering or fraud.

Section 16 regulatory

"for the purpose of Section 16 of the Securities and Exchange Act of 1934"

Section 16 is a U.S. securities law rule that governs the trading and disclosure obligations of company insiders — typically officers, directors and large shareholders — to promote transparency and deter unfair profit-taking. It requires insiders to publicly report their stock trades and allows companies or the issuer to reclaim quick, short-term profits from certain insider trades, like a scoreboard and a refund policy that help investors see and limit possible insider advantage.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did HBAN director Jeffrey L. Tate report?

Jeffrey L. Tate reported receiving stock awards of Huntington Bancshares common stock. These were compensation-related grants, not open-market purchases, increasing both his direct and deferred compensation plan holdings without any cash price per share.

How many HBAN shares were awarded to Jeffrey L. Tate on July 1, 2026?

On July 1, 2026, Jeffrey L. Tate received 44.146 Huntington Bancshares shares in a Director Deferred Compensation Plan and 525.900 shares as a direct award, all at a stated price of $0.0000 per share as part of his director compensation.

What are Jeffrey L. Tate’s HBAN share holdings after these awards?

After the July 1, 2026 awards, Jeffrey L. Tate is reported with 5,202.841 Huntington Bancshares shares held indirectly through a Director Deferred Compensation Plan and 123,460.753 shares held directly, reflecting an increase in his overall reported equity position.

Were Jeffrey L. Tate’s HBAN share awards open-market purchases?

No, the transactions were classified as grants or awards, not open-market purchases. The Form 4 shows a transaction code A, indicating compensation-related acquisitions of Huntington Bancshares common stock at a stated price of $0.0000 per share.

How are Jeffrey L. Tate’s indirect HBAN holdings structured?

Tate’s indirect holdings are reported under a Director Deferred Compensation Plan. The filing notes 5,202.841 Huntington Bancshares shares credited there after the transaction, with a disclaimer that the reporting should not be construed as an admission of beneficial ownership.

Does Jeffrey L. Tate disclaim beneficial ownership of some HBAN shares?

Yes. A statement attached to the report says it should not be construed as an admission that Jeffrey L. Tate is the beneficial owner of the reported securities for Section 16 or other purposes, which is a common legal disclaimer.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/06/2026 - 03:02 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Tate Jeffrey L.

(Last) (First) (Middle)

HUNTINGTON CENTER

41 S. HIGH STREET

(Street)

COLUMBUS OHIO 43215

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
HUNTINGTON BANCSHARES INC /MD/ [ HBAN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	07/01/2026		A		525.9	A	$0.0000	123,460.753	D
Common Stock	07/01/2026		A		44.146	A	$0.0000	5,202.841	I	Director Deferred Compensation Plan(1)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The filing of this statement shall not be construed as an admission that the undersigned is, for the purpose of Section 16 of the Securities and Exchange Act of 1934 or otherwise, the beneficial owner of the securities.

	Rachel L. Lawless, Attorney-in-Fact	07/06/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)